129 related articles for article (PubMed ID: 38461113)
1. Risk stratification model for the pharmaceutical care of oncology patients with solid or hematologic neoplasms.
Bernardez B; Mangues-Bafalluy I; Callejo VM; Ávila JJF; Rodríguez JAM; Aradilla MAP; Bautista MJM
Farm Hosp; 2024; 48(3):T108-T115. PubMed ID: 38461113
[TBL] [Abstract][Full Text] [Related]
2. Risk stratification model for the pharmaceutical care of oncology patients with solid or hematologic neoplasms.
Bernardez B; Mangues-Bafalluy I; Callejo VM; Ávila JJF; Rodríguez JAM; Aradilla MAP; Bautista MJM
Farm Hosp; 2024; 48(3):108-115. PubMed ID: 37884399
[TBL] [Abstract][Full Text] [Related]
3. TELEA-Farmacia: Pharmaceutical care by Telepharmacy to oncology patients from a hospital pharmacy service.
Castro-Balado A; Tourís-Lores M; Lema-Oreiro M; Bernárdez-Ferrán B; Zarra-Ferro I
Farm Hosp; 2022 Oct; 46(7):5-14. PubMed ID: 36520555
[TBL] [Abstract][Full Text] [Related]
4. Pharmaceutical care program for onco-hematologic outpatients: safety, efficiency and patient satisfaction.
Ribed A; Romero-Jiménez RM; Escudero-Vilaplana V; Iglesias-Peinado I; Herranz-Alonso A; Codina C; Sanjurjo-Sáez M
Int J Clin Pharm; 2016 Apr; 38(2):280-8. PubMed ID: 26715547
[TBL] [Abstract][Full Text] [Related]
5. Implementing a clinical pharmacy service in hematology.
Farias TF; Aguiar KD; Rotta I; Belletti KM; Carlotto J
Einstein (Sao Paulo); 2016; 14(3):384-390. PubMed ID: 27759828
[TBL] [Abstract][Full Text] [Related]
6. Survey of oncohematological pharmaceutical care situation in Spain.
Martínez-Bautista MJ; Mangues-Bafalluy I; Cajaraville-Ordoñana G; Carreras-Soler MJ; Clopés-Estela A; Moreno-Martínez E
Farm Hosp; 2019 Nov; 43(6):194-201. PubMed ID: 31705643
[TBL] [Abstract][Full Text] [Related]
7. Development of a risk stratification model for pharmaceutical care in HIV patients.
Morillo-Verdugo R; Martínez-Sesmero JM; Lázaro-López A; Sánchez-Rubio J; Navarro-Aznárez H; DeMiguel-Cascón M
Farm Hosp; 2017 May; 41(3):346-356. PubMed ID: 28478749
[TBL] [Abstract][Full Text] [Related]
8. [Analysis of the evolution of outpatient pharmaceutical care in hospital pharmacy services in Spain after the implementation and development of the MAPEX initiative].
Morillo Verdugo R; Vicente Escrig E; Murillo Izquierdo M; Ibarra Barrueta O; Taberner Bonastre P; Fernández-Llamazares CM
J Healthc Qual Res; 2024; 39(2):65-79. PubMed ID: 38160121
[TBL] [Abstract][Full Text] [Related]
9. Specialty pharmacy for hematologic malignancies.
Fajardo S; Zook F; Dotson E
Am J Health Syst Pharm; 2016 Jun; 73(11):797-809. PubMed ID: 27126835
[TBL] [Abstract][Full Text] [Related]
10. Impact of hematologic malignancy and type of cancer therapy on COVID-19 severity and mortality: lessons from a large population-based registry study.
García-Suárez J; de la Cruz J; Cedillo Á; Llamas P; Duarte R; Jiménez-Yuste V; Hernández-Rivas JÁ; Gil-Manso R; Kwon M; Sánchez-Godoy P; Martínez-Barranco P; Colás-Lahuerta B; Herrera P; Benito-Parra L; Alegre A; Velasco A; Matilla A; Aláez-Usón MC; Martos-Martínez R; Martínez-Chamorro C; Susana-Quiroz K; Del Campo JF; de la Fuente A; Herráez R; Pascual A; Gómez E; Pérez-Oteyza J; Ruiz E; Alonso A; González-Medina J; Martín-Buitrago LN; Canales M; González-Gascón I; Vicente-Ayuso MC; Valenciano S; Roa MG; Monteliu PE; López-Jiménez J; Escobar CE; Ortiz-Martín J; Diez-Martin JL; Martinez-Lopez J;
J Hematol Oncol; 2020 Oct; 13(1):133. PubMed ID: 33032660
[TBL] [Abstract][Full Text] [Related]
11. Impact of clinical pharmacy in oncology and hematology centers: A systematic review.
Oliveira CS; Silva MP; Miranda ÍKSPB; Calumby RT; de Araújo-Calumby RF
J Oncol Pharm Pract; 2021 Apr; 27(3):679-692. PubMed ID: 33302824
[TBL] [Abstract][Full Text] [Related]
12. A pilot study to assess the pharmacy impact of implementing a chemotherapy-induced nausea or vomiting collaborative disease therapy management in the outpatient oncology clinics.
Jackson K; Letton C; Maldonado A; Bodiford A; Sion A; Hartwell R; Graham A; Bondarenka C; Uber L
J Oncol Pharm Pract; 2019 Jun; 25(4):847-854. PubMed ID: 29587608
[TBL] [Abstract][Full Text] [Related]
13. [Health care models for patients with multiple chronic conditions and the role of the hospital pharmacy/the hospital pharmacist].
Santos-Ramos B; Otero López MJ; Galván-Banqueri M; Alfaro-Lara ER; Vega-Coca MD; Nieto-Martín MD; Ollero-Baturone M
Farm Hosp; 2012; 36(6):506-17. PubMed ID: 23461444
[TBL] [Abstract][Full Text] [Related]
14. [Translated article] Checklist for the pharmaceutical care of patients with interstitial lung disease (CheckEPID): A Delphi-based consensus.
Calvin-Lamas M; Calleja Hernández MÁ; Monte-Boquet E; Rodriguez Sagrado MÁ; Ventayol Bosch P
Farm Hosp; 2023; 47(6):T277-T284. PubMed ID: 37865593
[TBL] [Abstract][Full Text] [Related]
15. A survey about the contents and features of oncology clinical pharmacy services and self-evaluations of the oncology pharmacists in China.
Wang Y; Dai Y; Yang J; Zhou H; Chen Z; Li G
J Clin Pharm Ther; 2020 Oct; 45(5):1106-1113. PubMed ID: 32592203
[TBL] [Abstract][Full Text] [Related]
16. Checklist for Pharmaceutical Care of the Patient with interstitial lung disease (CheckEPID): A Delphi-based consensus.
Calvin Lamas M; Calleja Hernández MÁ; Monte-Boquet E; Rodriguez Sagrado MÁ; Ventayol Bosch P
Farm Hosp; 2023; 47(6):277-284. PubMed ID: 37516614
[TBL] [Abstract][Full Text] [Related]
17. Correlates of one-year mortality among patients living with HIV according to the stratification level of the pharmaceutical care model.
Contreras-Macías E; Robustillo-Cortés MLA; Morillo-Verdugo R
Enferm Infecc Microbiol Clin (Engl Ed); 2024; 42(6):302-307. PubMed ID: 37394400
[TBL] [Abstract][Full Text] [Related]
18. Humanistic outcomes in the hypertension and COPD arms of a multicenter outcomes study.
Gourley GA; Portner TS; Gourley DR; Rigolosi EL; Holt JM; Solomon DK; Bass GE; Wicke WR; Braden RL
J Am Pharm Assoc (Wash); 1998; 38(5):586-97. PubMed ID: 9782692
[TBL] [Abstract][Full Text] [Related]
19. Pharmaceutical services in nursing homes in Spain.
Fernández-Villalba EM; Gil-Gómez I; Peris-Martí JF; García-Mina Freire M; Delgado-Silveira E; Juanes-Borrego A
Farm Hosp; 2020 Jan; 44(1):3-9. PubMed ID: 31901055
[TBL] [Abstract][Full Text] [Related]
20. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
